Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy
Launched by THE UNIVERSITY OF HONG KONG · Jun 5, 2022
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether self-administered acupressure can help reduce cancer-related fatigue in breast cancer patients receiving chemotherapy, similar to the effects of aerobic exercise. The trial will involve 138 patients aged 18 and older who are about to start their first round of outpatient chemotherapy. Participants will be randomly assigned to either the acupressure group, where they will learn self-acupressure techniques with the help of a trained practitioner, or the aerobic exercise group, which will also include instruction from a fitness specialist. Both groups will practice on their own for 12 weeks.
To be eligible for the trial, participants must have a breast cancer diagnosis, have good health status (meaning they can carry out daily activities), and provide written consent. They should not have received acupressure or done significant exercise recently, nor should they be pregnant or have certain injuries. Throughout the study, researchers will look at various factors, including sleep quality and overall quality of life, to see how these two methods compare in helping patients feel better during chemotherapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. aged 18 or above
- • 2. with a diagnosis of breast cancer
- • 3. scheduled to commence their first cycle of outpatient adjuvant chemotherapy
- • 4. have an Eastern Cooperative Oncology Group performance status of 0 or 1
- • 5. screened as no contraindications for exercise based on a pre-exercise safety assessment (including aspects of blood results, cardiorespiratory signs and symptoms, metastasis, and variations in cognitive functions)
- • 6. written informed consent
- Exclusion Criteria:
- • 1. have received/self-administered acupressure or acupuncture in the previous 3 months
- • 2. have engaged in \>90 min of moderate intensity aerobic exercise per week in the previous 3 months
- • 3. are pregnant or lactating
- • 4. have any injury or ulcers around the acupoints
- • 5. unable to communicate in Cantonese, Mandarin, or English
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials